Literature DB >> 16905746

Saposin A mobilizes lipids from low cholesterol and high bis(monoacylglycerol)phosphate-containing membranes: patient variant Saposin A lacks lipid extraction capacity.

Silvia Locatelli-Hoops1, Natascha Remmel, Ralf Klingenstein, Bernadette Breiden, Maksim Rossocha, Maike Schoeniger, Christine Koenigs, Wolfram Saenger, Konrad Sandhoff.   

Abstract

Saposin A (Sap-A) is one of five known sphingolipid activator proteins required for the lysosomal degradation of sphingolipids and for the loading of lipid antigens onto antigen-presenting molecules of the CD1 type. Sap-A assists in the degradation of galactosylceramide by galactosylceramide-beta-galactosidase in vivo, which takes place at the surface of intraendosomal/intralysosomal vesicles. Sap-A is believed to mediate the interaction between the enzyme and its membrane-bound substrate. Its dysfunction causes a variant form of Krabbe disease. In the present study we prepared glycosylated Sap-A free of other Saps, taking advantage of the Pichia pastoris expression system. Using liposomes and surface plasmon resonance spectroscopy, we tested the binding and lipid mobilization capacity of Sap-A under different conditions. Along the endocytic pathway, the pH value decreases, and the lipid composition of intraendosomal and intralysosomal membranes changes drastically. In the inner membranes the cholesterol concentration decreases, and that of the anionic phospholipid bis(monoacylglycero)phosphate increases. Here, we show that Sap-A is able to bind to liposomes and to mobilize lipids out of them at acidic pH values below pH 4.7. Low cholesterol levels and increasing concentrations of bis(monoacylglycero)phosphate favor lipid extraction significantly. Galactosylceramide as a bilayer component is not essential for lipid mobilization by Sap-A, which requires intact disulfide bridges for activity. We also show for the first time that glycosylation of Sap-A is essential for its lipid extraction activity. Variant Sap-A proteins, which cause storage of galactosylceramide in humans (Krabbe disease, Spiegel, R., Bach, G., Sury, V., Mengistu, G., Meidan, B., Shalev, S., Shneor, Y., Mandel, H., and Zeigler, M. (2005) Mol. Genet. Metab. 84, 160-166) and in mutant mice (Matsuda, J., Vanier, M. T., Saito, Y., Tohyama, J., and Suzuki, K. (2001) Hum. Mol. Genet. 10, 1191-1199) are deficient in lipid extraction capacity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16905746     DOI: 10.1074/jbc.M607281200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Structure of saposin A lipoprotein discs.

Authors:  Konstantin Popovic; John Holyoake; Régis Pomès; Gilbert G Privé
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-02       Impact factor: 11.205

2.  Molecular imaging of membrane interfaces reveals mode of beta-glucosidase activation by saposin C.

Authors:  Jean-René Alattia; James E Shaw; Christopher M Yip; Gilbert G Privé
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-22       Impact factor: 11.205

Review 3.  Endosomal processing for antigen presentation mediated by CD1 and Class I major histocompatibility complex: roads to display or destruction.

Authors:  Marianne Boes; Arie J Stoppelenburg; Fenna C M Sillé
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

4.  Detecting Protein-Glycolipid Interactions Using CaR-ESI-MS and Model Membranes: Comparison of Pre-loaded and Passively Loaded Picodiscs.

Authors:  Jun Li; Ling Han; Jianing Li; Elena N Kitova; Zi Jian Xiong; Gilbert G Privé; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2018-04-13       Impact factor: 3.109

5.  Membrane lipids regulate ganglioside GM2 catabolism and GM2 activator protein activity.

Authors:  Susi Anheuser; Bernadette Breiden; Günter Schwarzmann; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2015-07-14       Impact factor: 5.922

Review 6.  Biological function of the cellular lipid BMP-BMP as a key activator for cholesterol sorting and membrane digestion.

Authors:  Hichem D Gallala; Konrad Sandhoff
Journal:  Neurochem Res       Date:  2010-12-07       Impact factor: 3.996

7.  Membrane lipids and their degradation compounds control GM2 catabolism at intralysosomal luminal vesicles.

Authors:  Susi Anheuser; Bernadette Breiden; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2019-04-15       Impact factor: 5.922

Review 8.  Lysosomal lipid storage diseases.

Authors:  Heike Schulze; Konrad Sandhoff
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

9.  Role of endosomal membrane lipids and NPC2 in cholesterol transfer and membrane fusion.

Authors:  Misbaudeen Abdul-Hammed; Bernadette Breiden; Matthew A Adebayo; Jonathan O Babalola; Günter Schwarzmann; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2010-02-23       Impact factor: 5.922

10.  Saposin B-dependent reconstitution of arylsulfatase A activity in vitro and in cell culture models of metachromatic leukodystrophy.

Authors:  Ulrich Matzner; Bernadette Breiden; Günter Schwarzmann; Afshin Yaghootfam; Arvan L Fluharty; Andrej Hasilik; Konrad Sandhoff; Volkmar Gieselmann
Journal:  J Biol Chem       Date:  2009-02-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.